145 related articles for article (PubMed ID: 20356563)
1. Structural binding evidence of the trypanocidal drugs berenil and pentacarinate active principles to a serine protease model.
Perilo CS; Pereira MT; Santoro MM; Nagem RA
Int J Biol Macromol; 2010 Jun; 46(5):502-11. PubMed ID: 20356563
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic evaluation and modeling of proton and water exchange associated with benzamidine and berenil binding to beta-trypsin.
Pereira MT; Silva-Alves JM; Martins-José A; Lopes JC; Santoro MM
Braz J Med Biol Res; 2005 Nov; 38(11):1593-601. PubMed ID: 16258627
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
[TBL] [Abstract][Full Text] [Related]
5. DNA multimode interaction with berenil and pentamidine; double helix stiffening, unbending and bending.
Reinert KE
J Biomol Struct Dyn; 1999 Oct; 17(2):311-31. PubMed ID: 10563581
[TBL] [Abstract][Full Text] [Related]
6. A crystallographic and spectroscopic study of the complex between d(CGCGAATTCGCG)2 and 2,5-bis(4-guanylphenyl)furan, an analogue of berenil. Structural origins of enhanced DNA-binding affinity.
Laughton CA; Tanious F; Nunn CM; Boykin DW; Wilson WD; Neidle S
Biochemistry; 1996 May; 35(18):5655-61. PubMed ID: 8639524
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
8. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
9. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition.
Dullweber F; Stubbs MT; Musil D; Stürzebecher J; Klebe G
J Mol Biol; 2001 Oct; 313(3):593-614. PubMed ID: 11676542
[TBL] [Abstract][Full Text] [Related]
10. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
Katz BA; Luong C
J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
[TBL] [Abstract][Full Text] [Related]
11. NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2.
Jenkins TC; Lane AN; Neidle S; Brown DG
Eur J Biochem; 1993 May; 213(3):1175-84. PubMed ID: 8504811
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
13. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
14. Competitive parabolic inhibition of bovine trypsin by bis-benzamidines.
Junqueira RG; Silva E; Mares-Guia M
Braz J Med Biol Res; 1992; 25(9):873-87. PubMed ID: 1342833
[TBL] [Abstract][Full Text] [Related]
15. In silico analysis of heparin and chondroitin sulfate binding mechanisms of the antiprotozoal drug berenil and pentamidine.
Samsonov SA; Freza S; Zsila F
Carbohydr Res; 2019 Aug; 482():107742. PubMed ID: 31310940
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamic and spectroscopic characterization of the berenil and pentamidine complexes with the dodecanucleotide d(CGCGATATCGCG)2.
Schmitz HU; Hübner W; Ackermann T
Z Naturforsch C J Biosci; 1995; 50(3-4):263-274. PubMed ID: 7766260
[TBL] [Abstract][Full Text] [Related]
17. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
18. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
[TBL] [Abstract][Full Text] [Related]
19. Receptor rigidity and ligand mobility in trypsin-ligand complexes.
Guvench O; Price DJ; Brooks CL
Proteins; 2005 Feb; 58(2):407-17. PubMed ID: 15578663
[TBL] [Abstract][Full Text] [Related]
20. Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin.
Talhout R; Villa A; Mark AE; Engberts JB
J Am Chem Soc; 2003 Sep; 125(35):10570-9. PubMed ID: 12940739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
